Overview
International law firm McDermott Will & Emery represented H.I.G. Capital, LLC (H.I.G.), a leading global alternative investment firm with $65 billion of capital under management, in the sale of its portfolio company, BIOVECTRA Inc. (BIOVECTRA) to Agilent Technologies, Inc.
BIOVECTRA is a Canada-based contract development and manufacturing organization for key ingredients used in branded drugs to treat a broad range of complex diseases. H.I.G. acquired BIOVECTRA in 2019.
The McDermott team was led by Harris Siskind, Alex Clavero, Maria Navarro and Brad Burcroff.
Read H.I.G.’s announcement here.
McDermott’s private equity (PE) practice is among the top four most active PE law firms globally and in the US with more than 160 dedicated PE lawyers across 21 locations. We have ranked Pitchbook’s Top 5 Healthcare PE firm for six consecutive years and are Top 10 in PE Buyouts and other PE deals. We are also ranked as a Top 10 Global Mid-Market PE Firm by Bloomberg and #7 PE Law firm by The Deal. Learn more about our PE practice by visiting pe.mwe.com.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
